.png){kind=icon}
.png){kind=icon}
Return
Update on pediatric autoimmune encephalitis-associated epilepsy
.png){kind=icon}
PRE
AI
C
C
DOI：10.1097/WCO.0000000000001472.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Autoimmune encephalitis-associated epilepsy (AEAE) is initially caused by an aberrant innate and/or adaptive immune system, and then the seizure nidus persists from the ensuing structural damage resulting in chronic, often drug-resistant epilepsy. Early identification and targeted immunomodulation may help improve long-term outcomes in some cases. This review summarizes current advances in understanding the diagnosis, treatment, and long-term outcomes for pediatric patients with AEAE.
Keywords:
acute symptomatic seizures
autoimmune encephalitis
autoimmune encephalitis-associated epilepsy
immunotherapy
Journal
IF:
4.4
Papers:
2.8K
Citations:
6.5K
Organization
No organization information available
Cited Papers